LAUREN P SILVERNAIL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LAUREN P SILVERNAIL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LAUREN P SILVERNAIL. LAUREN P SILVERNAIL is a CFO in ISTA PHARMACEUTICALS INC ($ISTA) and a Chief Financial Officer in ISTA PHARMACEUTICALS INC ($ISTA) and a CFO & CBO in Revance Therapeutics, Inc. ($RVNC) and a CFO, CBO & Secretary in Revance Therapeutics, Inc. ($RVNC) and a CFO, Secretary & EVP Corp Dev. in Revance Therapeutics, Inc. ($RVNC) and a See Remarks in Evolus, Inc. ($EOLS).
Address: 15279 ALTON PARKWAY SUITE 100 IRVINE 92618 CA
Companies in which LAUREN P SILVERNAIL is an Insider
Evolus, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAUREN P SILVERNAIL: See Remarks
Holdings: 180,689 shares
Latest Transaction: Feb 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ISTA PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAUREN P SILVERNAIL: Chief Financial Officer, CFO
Holdings: 58,120 shares
Latest Transaction: Feb 18 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revance Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of LAUREN P SILVERNAIL: CFO & CBO, CFO, CBO & Secretary, CFO, Secretary & EVP Corp Dev.
Holdings: 65,497 shares
Current Value: $1,355,788
Latest Transaction: May 24 2018
$RVNC Market Capitalization: $591.69M
$RVNC Previous Close: $20.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of LAUREN P SILVERNAIL
Sentiment: All, EOLS, ISTA, RVNC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 01 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 90,000 | 0 | 180,689 | 90.7 K to 180.7 K (+99.24 %) |
| Jan 26 2021 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 7.46 | 2,699 | 20,135 | 90,689 | 93.4 K to 90.7 K (-2.89 %) |
| May 15 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 40,000 | 0 | 93,388 | 53.4 K to 93.4 K (+74.92 %) |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Option Exercise | A | 10.19 | 45,000 | 458,550 | 45,000 | |
| Jan 24 2020 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Grant | A | 0.00 | 26,000 | 0 | 53,388 | 27.4 K to 53.4 K (+94.93 %) |
| May 31 2019 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 13.53 | 2,612 | 35,352 | 27,388 | 30 K to 27.4 K (-8.71 %) |
| May 31 2019 | EOLS | Evolus, Inc. | SILVERNAIL LAUREN P | See Remarks | Sell | S | 13.53 | 2,612 | 35,352 | 27,388 | 30 K to 27.4 K (-8.71 %) |